Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueTax ProvisionsTax Rate
Others
Ratios

Metlife (MET-PF) EBITDA (2016 - 2025)

Historic EBITDA for Metlife (MET-PF) over the last 17 years, with Q3 2025 value amounting to $3.2 billion.

  • Metlife's EBITDA fell 3391.9% to $3.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 billion, marking a year-over-year increase of 2046.15%. This contributed to the annual value of $21.3 billion for FY2024, which is 685.65% up from last year.
  • Latest data reveals that Metlife reported EBITDA of $3.2 billion as of Q3 2025, which was down 3391.9% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Metlife's EBITDA registered a high of $5.4 billion during Q4 2024, and its lowest value of -$7.3 billion during Q1 2021.
  • Moreover, its 5-year median value for EBITDA was $1.4 billion (2021), whereas its average is $804.5 million.
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 33405.17% in 2022, then surged by 602105.26% in 2025.
  • Quarter analysis of 5 years shows Metlife's EBITDA stood at $5.2 billion in 2021, then fell by 14.7% to $4.5 billion in 2022, then grew by 20.21% to $5.4 billion in 2023, then grew by 0.73% to $5.4 billion in 2024, then plummeted by 40.85% to $3.2 billion in 2025.
  • Its EBITDA stands at $3.2 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $3.0 billion for Q1 2025.